Active, not recruiting
Neoadjuvant Enoblituzumab (MGA271) in Men With Localized Intermediate and High-Risk Prostate Cancer
NCT02923180
- Conditions
- Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
- Locations
-
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States